October 9, 2015

Johnson & Johnson starts Ebola vaccine trial in Sierra Leone

Johnson & Johnson starts Ebola vaccine trial in Sierra Leone
In this Aug. 12, 2015 photo, people walk past a billboard warning residents to stop the stigmatization of Ebola survivors, in Kenema, eastern Sierra Leone. Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study being conducted in Sierra Leone's Kambia district, where some of the country's most recent Ebola cases have been reported. The company said Friday, Oct. 9, that the first volunteers have received the initial dose. (AP Photo/Sunday Alamba)

Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.

The regimen is part of a new study being conducted in that nation's Kambia district, where some of the country's most recent Ebola cases have been reported.

More than 11,000 people have died from the Ebola virus since the latest outbreak emerged in late 2013, nearly all of them in West Africa in and around Sierra Leone.

There is currently no licensed vaccine, treatment or cure for Ebola.

The Johnson & Johnson study, in development at subsidiary Janssen Pharmaceutical Cos., will evaluate safety and immune response within Sierra Leone's general population.

The company said Friday that the first volunteers have received the initial dose.

Johnson & Johnson, based in New Brunswick, New Jersey, said that there are separate studies being conducted in the U.S., Europe and Africa as part of the accelerated development plan to prevent Ebola outbreaks.

© 2015 The Associated Press. All rights reserved.

Citation: Johnson & Johnson starts Ebola vaccine trial in Sierra Leone (2015, October 9) retrieved 28 April 2024 from https://medicalxpress.com/news/2015-10-johnson-ebola-vaccine-trial-sierra.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Experts to investigate new Ebola case in north Sierra Leone
4 shares

Feedback to editors
Research shows 'profound' link between dietary choices and brain health

12 hours ago
Component of keto diet plus immunotherapy may reduce prostate cancer

16 hours ago
Study finds big jump in addiction treatment at community health clinics

16 hours ago
Positive childhood experiences can boost mental health and reduce depression and anxiety in teens

16 hours ago
Gene linked to epilepsy and autism decoded in new study

Apr 26, 2024
Blood test finds knee osteoarthritis up to eight years before it appears on X-rays

Apr 26, 2024
Researchers find pregnancy cytokine levels impact fetal brain development and offspring behavior

Apr 26, 2024
Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

Apr 26, 2024
Clinical trial evaluates azithromycin for preventing chronic lung disease in premature babies

Apr 26, 2024
Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progression

Apr 26, 2024
Load comments (0)